Publicacións en colaboración con investigadores/as de Clínica Universitaria de Navarra (36)

2025

  1. Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score

    European heart journal, Vol. 46, Núm. 3, pp. 273-284

  2. Bioinspired orthogonal-shaped protein–biometal nanocrystals enable oral protein absorption

    Journal of Controlled Release, Vol. 377, pp. 17-36

  3. Dataset from Bioinspired Orthogonal-Shaped Protein–Biometal Nanocrystals Enable Oral Protein Absorption

    Zenodo

  4. Dataset from Bioinspired Orthogonal-Shaped Protein–Biometal Nanocrystals Enable Oral Protein Absorption

    Zenodo

  5. Multiomics of the intestine-liver-adipose axis in multiple studies unveils a consistent link of the gut microbiota and the antiviral response with systemic glucose metabolism

    Gut, Vol. 74, Núm. 2, pp. 229-245

2024

  1. Localization, traffic and function of Rab34 in adipocyte lipid and endocrine functions

    Journal of Biomedical Science, Vol. 31, Núm. 1

2023

  1. Hepatic p63 regulates glucose metabolism by repressing SIRT1

    Gut, Vol. 72, Núm. 3, pp. 472-483

  2. Neddylation of phosphoenolpyruvate carboxykinase 1 controls glucose metabolism

    Cell Metabolism, Vol. 35, Núm. 9, pp. 1630-1645.e5

2021

  1. Long-term prognosis of women with Brugada syndrome and electrophysiological study

    Heart Rhythm, Vol. 18, Núm. 5, pp. 664-671

2018

  1. PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy

    Journal of Controlled Release, Vol. 276, pp. 125-139

2016

  1. Risk of pacemaker implantation after uneventful successful cavotricuspid isthmus radiofrequency ablation in patients with common atrial flutter

    International Journal of Cardiology, Vol. 202, pp. 285-288

2015

  1. Registro Español de Trasplante Cardiaco (Adultos). XXV Informe Oficial de la Sección de Insuficiencia Cardiaca y Trasplante Cardiaco de la Sociedad Española de Cardiología (1984-2013)

    Revista Espanola de Cardiologia Suplementos, Vol. 15, Núm. S2, pp. 31-42

  2. Targeting γ-secretases protect against angiotensin II-induced cardiac hypertrophy

    Journal of Hypertension

2014

  1. The neuroprotection exerted by memantine, minocycline and lithium, against neurotoxicity of CSF from patients with amyotrophic lateral sclerosis, is antagonized by riluzole

    Neurodegenerative Diseases, Vol. 13, Núm. 2-3, pp. 171-179

2013

  1. Dislipidemia en población diabé tica tratada con estatinas. Resultados del Dyslipidemia International Study en España

    Medicina Clinica, Vol. 141, Núm. 10, pp. 430-436

2011

  1. Anticoagulation prescription in atrial fibrillation

    Expert Opinion on Pharmacotherapy, Vol. 12, Núm. 10, pp. 1473-1479

  2. Prevalence and characteristics of lipid abnormalities in patients treated with statins in primary and secondary prevention in Spain. DYSIS-Spain study

    Revista Espanola de Cardiologia, Vol. 64, Núm. 4, pp. 286-294

2010

  1. Extracellular fatty acid synthase: A possible surrogate biomarker of insulin resistance

    Diabetes, Vol. 59, Núm. 6, pp. 1506-1511

2009

  1. Erectile dysfunction as a marker of silent cardiovascular disease in type-2 diabetic patients in Spain. The DIVA (DIabetes and VAscular disease) study

    Medicina Clinica, Vol. 132, Núm. 8, pp. 291-297

  2. Hypothalamic lipids and the regulation of energy homeostasis

    Obesity Facts, Vol. 2, Núm. 2, pp. 126-135